TrialPanorama/TrialPanorama-database huggingface dataset:
Study 34981142 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study 34982055 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34982337 — Predictive Biomarker (PRD): DDIT3 mRNA
Genes: DDIT3; CHOP; CHOP10; GADD153
Study 34982399 — Predictive Biomarker (PRD): COPE mRNA
Genes: COPE
Study 34983109 — Predictive Biomarker (PRD): MARS1 mRNA
Genes: MARS1; MARS
Study 34983430 — Monitoring Biomarker (MOI): Procalcitonin
Study 34983430 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 34983488 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 34983611 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34983621 — Predictive Biomarker (PRD): PPARGC1B mRNA
Genes: PPARGC1B; PERC; PGC1; PGC1B; PPARGC1
Study 34983758 — Predictive Biomarker (PRD): MANF mRNA
Genes: MANF; ARMET; ARP
Study 34983758 — Surrogate Endpoint (SUR): Blood pressure
Study 34986271 — Surrogate Endpoint (SUR): Blood pressure
Study 34987618 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34988299 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study 34989180 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 34989876 — Predictive Biomarker (PRD): C2 mRNA
Genes: C2
Study 34989876 — Monitoring Biomarker (MOI): Complement C7
Genes: C7
Study 34990207 — Surrogate Endpoint (SUR): Blood pressure
Study 34990408 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34990411 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 34990810 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34990810 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34991520 — Predictive Biomarker (PRD): C1QL1 mRNA
Genes: C1QL1; C1QRF; CRF; CTRP14
Study 34991520 — Predictive Biomarker (PRD): ID1 mRNA
Genes: ID1; BHLHB24; ID
Study 34991703 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 34991937 — Predictive Biomarker (PRD): LDLR mRNA
Genes: LDLR
Study 34992093 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 34992093 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34992093 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 34992825 — Surrogate Endpoint (SUR): Pathological complete response
Study 34993171 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 34993850 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 34993850 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 34994617 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34995640 — Predictive Biomarker (PRD): LAMB2 mRNA
Genes: LAMB2; LAMS
Study 34995818 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 34997316 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 34997316 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 34997701 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 34997825 — Surrogate Endpoint (SUR): Serum potassium
Study 34998092 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34998471 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 34999659 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 35001051 — Safety Biomarker (SAF): Hyaluronic acid
Study 35001562 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study 35003094 — Predictive Biomarker (PRD): IL1RAP mRNA
Genes: IL1RAP; C3orf13; IL1R3
Study 35005654 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 35005781 — Predictive Biomarker (PRD): Hormone receptor
Study 35005800 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 35007144 — Predictive Biomarker (PRD): TBXT mRNA
Genes: TBXT; T
Study 35007745 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 35008361 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 35008361 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 35010948 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 35012012 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 35012012 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 35012623 — Surrogate Endpoint (SUR): Forced vital capacity
Study 35012901 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 35013314 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35013314 — Predictive Biomarker (PRD): Hormone receptor
Study 35014537 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 35014537 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 35014900 — Predictive Biomarker (PRD): FBP1 mRNA
Genes: FBP1; FBP
Study 35015819 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 35015837 — Surrogate Endpoint (SUR): Blood pressure
Study 35015879 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study 35015980 — Surrogate Endpoint (SUR): Blood pressure
Study 35016146 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Growth/differentiation factor 15
Genes: GDF15; MIC1; PDF; PLAB; PTGFB
Study 35016694 — Predictive Biomarker (PRD): SPARC mRNA
Genes: SPARC; ON
Study 35017496 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35018553 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 35018639 — Surrogate Endpoint (SUR): Blood pressure
Study 35020119 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35020854 — Predictive Biomarker (PRD): FGL2 mRNA
Genes: FGL2
Study 35020854 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 35020854 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 35020854 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35020854 — Predictive Biomarker (PRD): SELE mRNA
Genes: SELE; ELAM1
Study 35020854 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): GZMB mRNA
Genes: GZMB; CGL1; CSPB; CTLA1; GRB
Study 35020854 — Predictive Biomarker (PRD): CIITA mRNA
Genes: CIITA; MHC2TA
Study 35020854 — Predictive Biomarker (PRD): UBD mRNA
Genes: UBD; FAT10
Study 35020854 — Predictive Biomarker (PRD): LSP1 mRNA
Genes: LSP1; WP34
Study 35020854 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 9
Genes: CXCL9; CMK; MIG; SCYB9
Study 35021220 — Predictive Biomarker (PRD): LCORL mRNA
Genes: LCORL
Study 35021220 — Predictive Biomarker (PRD): P2RX7 mRNA
Genes: P2RX7
Study 35021220 — Predictive Biomarker (PRD): PIK3C2B mRNA
Genes: PIK3C2B
Study 35021220 — Predictive Biomarker (PRD): NUMBL mRNA
Genes: NUMBL
Study 35022035 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 35022035 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35022299 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 35022321 — Predictive Biomarker (PRD): DRD2 mRNA
Genes: DRD2
Study 35022322 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 35022322 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 35022448 — Surrogate Endpoint (SUR): Serum uric acid
Study 35022790 — Predictive Biomarker (PRD): COL4A5 mRNA
Genes: COL4A5
Study 35022790 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 35024375 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35024375 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35025128 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study 35025762 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study 35026476 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 35027051 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 35027051 — Monitoring Biomarker (MOI): Cell-free DNA
Study 35027656 — Monitoring Biomarker (MOI): Cell-free DNA
Study 35027909 — Surrogate Endpoint (SUR): Bone mineral density
Study 35029044 — Monitoring Biomarker (MOI): HBV DNA
Study 35029189 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35029517 — Predictive Biomarker (PRD): CNR1 mRNA
Genes: CNR1; CNR
Study 35029517 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 35029841 — Predictive Biomarker (PRD): DCD mRNA
Genes: DCD; AIDD; DSEP
Study 35030234 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35030234 — Monitoring Biomarker (MOI): Alpha-1-acid glycoprotein 1
Genes: ORM1; AGP1
Study 35031227 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 35031545 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35031547 — Predictive Biomarker (PRD): IL7 mRNA
Genes: IL7
Study 35031547 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35032562 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 35033092 — Predictive Biomarker (PRD): RALA mRNA
Genes: RALA; RAL
Study 35033182 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35033182 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35033490 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD
Study 35033576 — Monitoring Biomarker (MOI): Cell-free DNA
Study 35033999 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 35033999 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 35033999 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35034046 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 35034046 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 35034046 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35035233 — Surrogate Endpoint (SUR): Blood pressure
Study 35035955 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35035955 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35037034 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Growth/differentiation factor 15
Genes: GDF15; MIC1; PDF; PLAB; PTGFB
Study 35037052 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 35037228 — Surrogate Endpoint (SUR): Serum sodium
Study 35039142 — Surrogate Endpoint (SUR): Blood pressure
Study 35039291 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35039952 — Predictive Biomarker (PRD): Hormone receptor
Study 35040156 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35040156 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35040160 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 35040945 — Surrogate Endpoint (SUR): Forced vital capacity
Study 35041128 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35041493 — Predictive Biomarker (PRD): ETV1 mRNA
Genes: ETV1; ER81
Study 35041493 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 35041751 — Surrogate Endpoint (SUR): Bone mineral density
Study 35042449 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 35042704 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35043384 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35043384 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35043976 — Predictive Biomarker (PRD): SLC16A4 mRNA
Genes: SLC16A4; MCT4; MCT5
Study 35043976 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-X-C motif chemokine 10
Genes: CXCL10; INP10; SCYB10
Study 35043976 — Safety Biomarker (SAF): Reactive oxygen species
Study 35045184 — Monitoring Biomarker (MOI): Urokinase plasminogen activator surface receptor
Genes: PLAUR; MO3; UPAR
Study 35045358 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35046010 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35046056 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 35046056 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 35046056 — Predictive Biomarker (PRD): BCL6 mRNA
Genes: BCL6; BCL5; LAZ3; ZBTB27; ZNF51
Study 35046059 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35046060 — Predictive Biomarker (PRD): DLL3 mRNA
Genes: DLL3
Study 35046063 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study 35046063 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 35046093 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35046124 — Surrogate Endpoint (SUR): Blood pressure
Study 35046747 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35047011 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study 35050743 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 35050780 — Predictive Biomarker (PRD): GRAP2 mRNA
Genes: GRAP2; GADS; GRB2L; GRID
Study 35051703 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 35051703 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study 35051737 — Surrogate Endpoint (SUR): Forced vital capacity
Study 35058326 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 35058326 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 35058354 — Monitoring Biomarker (MOI): Cell-free DNA
Study 35058882 — Predictive Biomarker (PRD): SSTR2 mRNA
Genes: SSTR2
Study 35060479 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35061093 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35061234 — Predictive Biomarker (PRD): JAK1
Genes: JAK1A; JTK3
Study 35061249 — Surrogate Endpoint (SUR): Serum creatinine
Study 35063222 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35063229 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 35063229 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35063276 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 35063276 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 35063276 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study 35064011 — Predictive Biomarker (PRD): Microsatellite instability
Study 35064249 — Surrogate Endpoint (SUR): Blood pressure
Study 35065785 — Predictive Biomarker (PRD): ARSA mRNA
Genes: ARSA
Study 35065801 — Predictive Biomarker (PRD): CFI mRNA
Genes: CFI; IF
Study 35065801 — Surrogate Endpoint (SUR): Blood pressure
Study 35066090 — Safety Biomarker (SAF): Vitamin K-dependent protein C
Genes: PROC
Study 35066175 — Predictive Biomarker (PRD): CFI mRNA
Genes: CFI; IF
Study 35066693 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 35066693 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study 35066801 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35066801 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 35067072 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 35068788 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 35068788 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 35070795 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 35070991 — Predictive Biomarker (PRD): HDAC6 mRNA
Genes: HDAC6; KIAA0901; JM21
Study 35072135 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 35072135 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 35072628 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35073935 — Predictive Biomarker (PRD): LRRC34 mRNA
Genes: LRRC34
Study 35073963 — Predictive Biomarker (PRD): CHM mRNA
Genes: CHM; REP1; TCD
Study 35073985 — Surrogate Endpoint (SUR): Blood pressure
Study 35074000 — Surrogate Endpoint (SUR): Blood pressure
Study 35074072 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 35075288 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 35075288 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 35075363 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 35075450 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35076026 — Predictive Biomarker (PRD): ABCA4 mRNA
Genes: ABCA4; ABCR
Study 35076282 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 35076300 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 35076300 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 35076335 — Predictive Biomarker (PRD): PEBP1 mRNA
Genes: PEBP1; PBP; PEBP
Study 35076703 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 35076812 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35076812 — Predictive Biomarker (PRD): Hormone receptor
Study 35076939 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 35078538 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35078972 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study 35078975 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35080147 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35080147 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35080267 — Predictive Biomarker (PRD): DCD mRNA
Genes: DCD; AIDD; DSEP
Study 35080734 — Surrogate Endpoint (SUR): Blood pressure
Study 35080773 — Safety Biomarker (SAF): Interleukin 1
Study 35080914 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 35081092 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 35081094 — Predictive Biomarker (PRD): LAMP2 mRNA
Genes: LAMP2
Study 35081293 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 35081550 — Predictive Biomarker (PRD): DHDDS mRNA
Genes: DHDDS; HDS
Study 35081732 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35082313 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 35082514 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 35082514 — Predictive Biomarker (PRD): DNAH17 mRNA
Genes: DNAH17; DNAHL1; DNEL2
Study 35082514 — Predictive Biomarker (PRD): ABCA1 mRNA
Genes: ABCA1; ABC1; CERP
Study 35082572 — Predictive Biomarker (PRD): PTPRF mRNA
Genes: PTPRF; LAR
Study 35083234 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35083365 — Surrogate Endpoint (SUR): Hemagglutination inhibition antibody
Study 35084335 — Predictive Biomarker (PRD): FMO3 mRNA
Genes: FMO3
Study 35084435 — Predictive Biomarker (PRD): EDNRA mRNA
Genes: EDNRA; ETA; ETRA
Study 35084435 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 35085007 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study 35085538 — Monitoring Biomarker (MOI): Cell-free DNA
Study 35086123 — Predictive Biomarker (PRD): ASIC3 mRNA
Genes: ASIC3; ACCN3; SLNAC1; TNAC1
Study 35086148 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 35086148 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study 35086504 — Predictive Biomarker (PRD): CPD mRNA
Genes: CPD
Study 35086719 — Safety Biomarker (SAF): Reactive oxygen species
Study 35086946 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 35087031 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 35087031 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study 35088348 — Predictive Biomarker (PRD): CCL20 mRNA
Genes: CCL20; LARC; MIP3A; SCYA20
Study 35088348 — Predictive Biomarker (PRD): CCL22 mRNA
Genes: CCL22; MDC; SCYA22; A-152E5.1
Study 35088348 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 35088709 — Surrogate Endpoint (SUR): Blood pressure
Study 35088733 — Predictive Biomarker (PRD): EEF1A2 mRNA
Genes: EEF1A2; EEF1AL; STN
Study 35089671 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 35089812 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 35090035 — Surrogate Endpoint (SUR): Serum creatinine
Study 35090169 — Surrogate Endpoint (SUR): Bone mineral density
Study 35091441 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 35091441 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study 35091443 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 35091442 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study 35091442 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 35091448 — Predictive Biomarker (PRD): LRP1 mRNA
Genes: LRP1; A2MR; APR
Study 35091445 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35091445 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 35091445 — Predictive Biomarker (PRD): LAG3 mRNA
Genes: LAG3; FDC